These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet. Wiggins JE; Goyal M; Wharram BL; Wiggins RC J Am Soc Nephrol; 2006 May; 17(5):1382-7. PubMed ID: 16597684 [TBL] [Abstract][Full Text] [Related]
5. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165 [TBL] [Abstract][Full Text] [Related]
6. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms]. Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury. Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008 [TBL] [Abstract][Full Text] [Related]
8. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy]. Wanke R; Wolf E; Brem G; Hermanns W Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406 [TBL] [Abstract][Full Text] [Related]
9. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Fries JW; Sandstrom DJ; Meyer TW; Rennke HG Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515 [TBL] [Abstract][Full Text] [Related]
10. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Amann K; Nichols C; Tornig J; Schwarz U; Zeier M; Mall G; Ritz E Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960 [TBL] [Abstract][Full Text] [Related]
11. FSGS as an Adaptive Response to Growth-Induced Podocyte Stress. Nishizono R; Kikuchi M; Wang SQ; Chowdhury M; Nair V; Hartman J; Fukuda A; Wickman L; Hodgin JB; Bitzer M; Naik A; Wiggins J; Kretzler M; Wiggins RC J Am Soc Nephrol; 2017 Oct; 28(10):2931-2945. PubMed ID: 28720684 [TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717 [TBL] [Abstract][Full Text] [Related]
13. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701 [TBL] [Abstract][Full Text] [Related]
14. Podocyte lesions in patients with obesity-related glomerulopathy. Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996 [TBL] [Abstract][Full Text] [Related]
15. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective. Hodgin JB; Bitzer M; Wickman L; Afshinnia F; Wang SQ; O'Connor C; Yang Y; Meadowbrooke C; Chowdhury M; Kikuchi M; Wiggins JE; Wiggins RC J Am Soc Nephrol; 2015 Dec; 26(12):3162-78. PubMed ID: 26038526 [TBL] [Abstract][Full Text] [Related]
16. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090 [TBL] [Abstract][Full Text] [Related]
17. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708 [TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Kuhlmann A; Haas CS; Gross ML; Reulbach U; Holzinger M; Schwarz U; Ritz E; Amann K Am J Physiol Renal Physiol; 2004 Mar; 286(3):F526-33. PubMed ID: 14600034 [TBL] [Abstract][Full Text] [Related]
19. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats. Ijpelaar DH; Schulz A; Koop K; Schlesener M; Bruijn JA; Kerjaschki D; Kreutz R; de Heer E Am J Physiol Renal Physiol; 2008 Apr; 294(4):F758-67. PubMed ID: 18199599 [TBL] [Abstract][Full Text] [Related]
20. De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy. Zhang J; Hansen KM; Pippin JW; Chang AM; Taniguchi Y; Krofft RD; Pickering SG; Liu ZH; Abrass CK; Shankland SJ Am J Physiol Renal Physiol; 2012 Mar; 302(5):F571-80. PubMed ID: 22129965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]